Verpora

What Verpora does

Verpora is a UK-based life sciences consultancy specializing in market access strategy, innovative contracting, and pharmaceutical business intelligence. The company serves global pharmaceutical manufacturers, biotech firms, and life sciences organizations seeking to improve patient access to high-cost medicines through evidence-based value articulation, payer engagement, and capability development. Its operational reach spans 45 markets with a curated network of 150+ current and former payers across EU, US, EMEA, APAC, and LATAM regions.

The company's core technology asset is VSTx (Verpora Specialist Treatment Data), a proprietary data intelligence product delivering indication-level, sub-national prescribing insights for high-cost drugs across UK secondary care organizations. VSTx encompasses four sub-products: Market Indication Reports, Molecule Indication Reports, New Patient Share, and Therapy Duration Reports, tracking prescribing behavior across 500+ indications. Complementing VSTx is the INSPIRE! access strategy methodology and a consulting suite including Commercial Negotiation Strategy, CMS Medicare Drug Price Negotiation Strategy (delivered with Manatt Health), Innovative & Value-Based Contracting Playbooks, and Custom Research. The Capabilities & Development arm delivers aviation-inspired training programs (Mayday at 8 Miles a Minute, Dare2Debrief) co-designed and co-delivered with current and former commercial and military pilots.

Verpora monetizes through three revenue streams: subscription-based VSTx data products, professional services for access strategy and contracting advisory, and corporate training engagements. The model is quote-based and customized to client scope with no public pricing. Distribution is direct enterprise sales through dedicated account directors. The company is led by CEO Nick Merryfield, with Head of Payers Omar Ali (former NICE, 30+ years payer-side experience) anchoring the payer network, supported by VPs across Innovative Contracting, Business Insights, Data & Analytics, Human Performance, and Commercial Accounts. Verpora Limited operates as part of Verpora Group and is registered in England and Wales (company number 09872632).

Name

Verpora

Legal name

Verpora Limited

Website

https://verpora.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Verpora is a UK-based life sciences consultancy that helps global pharmaceutical manufacturers secure patient access through proprietary drug prescribing intelligence (VSTx), innovative contracting strategy, and aviation-inspired team capability development, serving pharma and biotech clients across 45 markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Marketing Consulting Services (541613), Custom Computer Programming Services (541511)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)

Keywords

• Pharmaceutical market access
• Innovative contracting strategy
• Drug prescribing analytics
• Payer engagement consulting
• Value-based agreements

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Business Insights (VSTx Reports): Subscription-based access to VSTx data intelligence products including Market Indication Reports, Molecule Indication Reports, New Patient Share analysis, and Therapy Duration Reports. Delivered to pharmaceutical manufacturers for forecasting, resource allocation, and strategic planning.
2. Access Strategy Consulting: Advisory services including global strategy development, contracting playbooks, CMS negotiation strategy, commercial negotiation strategy, and custom research projects. Delivered through structured engagements with pharmaceutical clients.
3. Capabilities & Development Programs: Training programs delivered with commercial pilots and industry specialists including Crisis Leadership (Mayday at 8 Miles a Minute), Dare2Debrief team learning, and negotiation excellence programs. Offered as in-person workshops or online sessions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Verpora provides the inside track to creating and deploying successful market access strategies across the global life sciences industry through three integrated service lines: VSTx, a proprietary data intelligence platform delivering indication-level, sub-national prescribing insights for high-cost drugs across UK secondary care; access strategy consulting including innovative contracting, CMS negotiation strategy, and commercial negotiation; and capabilities development programs using aviation-inspired human performance training. The offerings target pharmaceutical and life sciences manufacturers to improve patient access to medicines through evidence-based intelligence, strategic frameworks, and team capability building.

Product overview

Verpora is a life science industry consultancy offering a unified portfolio of data intelligence and advisory services centered on market access, pricing strategy, and innovative contracting. The core product is VSTx (Verpora Specialist Treatment Data), a data intelligence suite providing indication-level, sub-national drug prescribing visibility across UK secondary care, comprising Market Indication Reports, Molecule Indication Reports, New Patient Share, and Therapy Duration Reports. This is complemented by the INSPIRE! access strategy methodology and associated consulting services including Commercial Negotiation Strategy, CMS Medicare Drug Price Negotiation Strategy, and Innovative & Value-Based Contracting Playbooks. The Capabilities & Development arm delivers aviation-inspired training programs (Mayday at 8 Miles a Minute, Dare2Debrief) for human performance and leadership. On-demand educational content includes The Payer Exchange Podcast and IC Fireside Chats video series. Custom Research Projects leveraging a global payer network round out the service offering.

Differentiator

Problem solved

Functional benefit

Brands

• VSTx: Verpora's precision intelligence product providing indication-level, sub-national high-cost drug prescribing data across UK secondary care organizations. Includes Market Indication Reports, Molecule Indication Reports, New Patient Share, and Therapy Duration Reports.

Products and services

• VSTx (Verpora Specialist Treatment Data) A data intelligence product delivering indication-level, sub-national visibility of high-cost drug prescribing across UK secondary care organizations. VSTx translates trust and health board-level data into structured insight to support resource allocation, forecasting, and strategic planning for pharmaceutical manufacturers.
• VSTx Market Indication Reports Precision insights into own and competitor product use for each indication, enabling competitive advantage and confident market positioning for pharmaceutical teams.
• VSTx Molecule Indication Reports Total visibility of patient share across all indications for a molecule, providing comprehensive understanding of a product's footprint and lifecycle value optimization.
• VSTx New Patient Share Identification of new patient starts by indication for own and competitor products, enabling organizations to turn lead indicators into market leadership.
• VSTx Therapy Duration Report Real-world data on patients' duration of therapy by indication, enabling refined forecasts and identification of intervention points to improve patient retention.
• INSPIRE! Access Strategy Methodology An access strategy methodology focused on shifting personal and organizational mindsets to improve patient access to life-enhancing technologies. Delivered through structured frameworks from global strategy to local execution.
• Commercial Negotiation Strategy A negotiation strategy and operationalization program that equips teams with advanced skills to control positioning, anchoring, and high-stakes customer dynamics, embedding negotiation excellence across organizations.
• CMS Medicare Drug Price Negotiation Strategy An end-to-end strategy and execution program combining clinical value story refinement, pricing ambition, CMS simulations, and negotiation excellence to optimize Maximum Fair Price outcomes for IPAY (CMS Medicare Drug Price Negotiation) negotiations.
• Innovative & Value-Based Contracting Playbooks A tailored, market-tested playbook of high-impact contracting frameworks designed to align payer priorities with brand strategy and unlock sustainable patient access.
• Custom Research Projects Rapid response research projects leveraging Verpora's US and global network of 150+ payers and UK oncology pharmacy expert network to address specific business questions for pharmaceutical clients.
• Mayday at 8 Miles a Minute An immersive aviation crisis scenario delivered with commercial and former military pilots, placing participants inside a real operational incident to explore team communication, challenge, and response under time and information pressure.
• Dare2Debrief A team learning and reflection program adapted from aviation's routine mission debriefs, introducing a structured approach to help teams reflect openly, capture lessons, and improve collaboration after complex situations.

Quantifiable outcome

• >$5B generated from improved contract negotiations for clients
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core, minor and supporting.

• Manatt HealthcoreStrategic or Co-development PartnerStrategic advisory partnership for IPAY (Medicare Drug Price Negotiation Program) support. Joint team of advisors spanning negotiation strategy, legal and regulatory counsel, government health technology assessment, and human performance factors. Delivers webinars and recommendations for manufacturers navigating CMS negotiations.
• BHBIAcoreStrategic or Co-development PartnerBritish Healthcare Business Intelligence Association membership. All Verpora team members are BHBIA-certified and committed to industry best practice. Verpora presents at BHBIA events including Annual Conference and Winter Seminar.
• Access2HealthminorStrategic or Co-development PartnerPaola Valinotti, Founder of Access2Health, co-presents Verpora's masterclass on scaling international access. Partnership brings additional expertise in international market access capability development.
• Amazon AWSsupportingTechnology or IntegrationCloud infrastructure provider used for data hosting. AWS Data Processing Agreement in place for personal data processing.
• HubSpotsupportingTechnology or IntegrationCRM software provider used for customer relationship management. HubSpot Data Processing Agreement in place for personal data processing.
• GooglesupportingTechnology or IntegrationAnalytics provider (Google Analytics) and search information provider. Google Analytics Data Processing Agreement in place for personal data processing.

Scale indicators7 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• IQVIA: Global leader in life sciences data, analytics, and commercial / market access consulting. Comparable because IQVIA offers real-world prescribing data and market access advisory that overlap with Verpora's VSTx and Access Strategy services, though at vastly greater scale across many more geographies.
• Definitive Healthcare: Provider of healthcare commercial intelligence, including prescribing, claims, and account data for life sciences customers. Comparable as a data intelligence competitor to VSTx, but at much broader scope (US-centric, multiple data layers).
• Fishawack Health: Global life sciences commercialization partner offering market access, medical communications, and consulting services. Overlaps with Verpora's Access Strategy and Capabilities Development offerings, but operates at much greater scale across multiple service lines.
• Syneos Health Consulting: Biopharma solutions organization with consulting and commercialization services including pricing, market access, and evidence strategy. Comparable on advisory scope targeting pharma manufacturers, though Verpora is more focused on innovative contracting specifically.

Direct peers

• Charles River Associates: Management consultancy with a Life Sciences practice focused on pricing, market access, and value-based contracting strategy. Direct peer to Verpora's Access Strategy and Innovative Contracting offerings, serving the same pharma manufacturer buyer base with similar advisory depth.
• Lattice (an Informa company): Pharma commercial and market access consulting firm serving global manufacturers on pricing, access, and launch strategy. Comparable on consulting scope, customer profile, and value-based contracting expertise, but larger and broader geographically than Verpora.
• Putnam Associates: Strategy consultancy dedicated to biopharma and life sciences with deep pricing, market access, and HEOR practices. Direct peer serving the same pharma customers on access strategy and contracting decisions, with broader functional breadth than Verpora.
• MAP BioPharma: UK-based market access consultancy supporting pharma with pricing, reimbursement, and HTA submissions. Highly comparable to Verpora on UK-centric access strategy and customer base, though with less proprietary data and global payer network reach.
• Health Advances: Strategy consulting firm advising biopharma, medtech, and diagnostics clients on commercialization, market access, and pricing. Comparable to Verpora's Access Strategy work for similar pharma and biotech buyer segments.
• WG Consulting: Specialist pharmaceutical market access and value-based contracting consultancy supporting global pharma with pricing and reimbursement strategy. Direct peer to Verpora's innovative contracting playbooks and payer engagement work, with similar boutique positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/verpora
• Xx.com/VerporaVBA

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verpora